Skip to main content
Skip to main content
BIOX logo

Bioceres Crop Solutions Corp. (BIOX)

$0.36 +$0.03 (+9.70%) |CouncilHOLD · 42 · C
Bottom line: HOLD — our Council read (42/100) and AI Score (42/100) broadly agree.
MCap: $22.96M| Vol: 132.5K| Target: $2.00 (+450.8%)| 52-wk range: $0.35 – $5.15
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Bioceres Crop Solutions Corp. (BIOX) trades at $0.36 with AI Score 42/100 (Grade C). Bioceres Crop Solutions Corp. provides crop productivity solutions through seed and integrated products, crop protection, and crop nutrition. Market cap: $22.96M, Sector: Basic materials.

Price live · AI analysis from May 10, 2026
Bioceres Crop Solutions Corp. provides crop productivity solutions through seed and integrated products, crop protection, and crop nutrition. The company operates internationally, focusing on developing and commercializing technologies for enhanced agricultural outcomes.

BIOX stock analysis for 2026: Analysts have set a consensus price target of $2.00 for Bioceres Crop Solutions Corp., suggesting 450.8% upside from the current price of $0.36. The AI MoonshotScore is 42/100, indicating a neutral outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
HOLD 42/100 · C

BIOX: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Bioceres Crop Solutions Corp. (BIOX) Materials & Commodity Exposure

CEOFederico Trucco
Employees400
HeadquartersRosario, AR
IPO Year2018

Bioceres Crop Solutions Corp. delivers crop productivity solutions across seed technology, crop protection, and nutrition, operating in Argentina, Uruguay, France, South Africa, and other international markets. The company's focus on biotechnological events and drought-tolerant seed programs like HB4 positions it within the agricultural inputs sector.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for BIOX?

Bioceres Crop Solutions Corp. presents a compelling investment thesis based on its focus on innovative agricultural technologies and international market presence. The company's HB4 drought-tolerant seed technology offers a significant value proposition in regions facing water scarcity. Key value drivers include the expansion of HB4 technology adoption and the growth of its crop protection and nutrition segments. With a market capitalization of $22.96M, Bioceres operates with a gross margin of 37.1%. However, the company's negative profit margin of -82.8% indicates ongoing challenges in achieving profitability. Future growth hinges on successful commercialization of its technologies and effective cost management. Investors should monitor the company's ability to improve profitability and expand its market share in key regions.

Based on FMP financials and quantitative analysis

BIOX Key Highlights

  • Market capitalization of $22.96M reflects its current valuation in the agricultural solutions market.
  • Gross margin of 37.1% indicates the company's ability to generate revenue from its products and services.
  • HB4 drought-tolerant seed technology offers a potential competitive advantage in water-stressed regions.
  • Operations in Argentina, Uruguay, France, and South Africa provide geographic diversification.
  • Negative profit margin of -82.8% highlights the need for improved cost management and profitability.

Who Are BIOX's Competitors?

BIOX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
BAYRY Bayer AG $14.56 -4.11% $57.24B 51
CTVA Corteva, Inc. $86.01 +0.24% $57.53B 82
MBII Marrone Bio Innovations, Inc. $0.80 -20.19% 68
AGRZ Agroz Inc. $0.39 -2.16% $8.45M 61
KNGW Kenongwo Group US, Inc. $0.32 +0.00% $32.60M 59
BHST BioHarvest Sciences Inc. $3.00 +4.53% $51.98M 59
AVD American Vanguard Corporation $3.16 +0.00% $90.39M 42
KPLUF K+S AG $20.70 +23.21% $3.71B 42

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are BIOX's Key Strengths?

  • Innovative HB4 drought-tolerant technology.
  • Diversified product portfolio across seed, crop protection, and nutrition.
  • International presence in key agricultural markets.
  • Focus on sustainable agricultural practices.

What Are BIOX's Weaknesses?

  • Negative profit margin.
  • Relatively small market capitalization.
  • Dependence on specific technologies and markets.
  • Limited brand recognition compared to larger competitors.

What Could Drive BIOX Stock Higher?

  • Expansion of HB4 technology adoption in key agricultural regions.
  • Growth in the biological crop protection and nutrition segments.
  • Potential strategic partnerships and acquisitions to expand market reach.
  • Development and commercialization of new sustainable agricultural solutions.

What Are the Key Risks for BIOX?

  • Financial-distress signal — its Altman Z-Score of 0.22 sits in the distress zone (elevated bankruptcy risk).
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Competition from larger, more established players in the agricultural inputs industry.
  • Regulatory changes and environmental concerns affecting the use of certain crop protection products.
  • Fluctuations in commodity prices and weather patterns impacting crop yields and demand.
  • Economic and political instability in key markets, particularly in Argentina.

What Are the Growth Opportunities for BIOX?

  • Expansion of HB4 Technology: The HB4 drought-tolerant seed technology represents a significant growth opportunity for Bioceres. As climate change intensifies and water scarcity becomes more prevalent, the demand for drought-resistant crops is expected to increase. The company can leverage this trend by expanding the adoption of HB4 technology in key markets, particularly in regions prone to drought. The global market for drought-tolerant crops is projected to reach billions of dollars, offering substantial revenue potential for Bioceres. Timeline: Ongoing.
  • Growth in Crop Protection Segment: The Crop Protection segment offers growth potential through the development and commercialization of innovative and sustainable crop protection products. With increasing concerns about the environmental impact of traditional pesticides, there is a growing demand for biological and eco-friendly alternatives. Bioceres can capitalize on this trend by expanding its portfolio of Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The global market for biological crop protection is expected to grow significantly, providing opportunities for Bioceres to increase its market share. Timeline: Ongoing.
  • Development of Crop Nutrition Segment: Bioceres has the opportunity to further develop its Crop Nutrition segment by focusing on inoculants, bio-inductors, and biological and microgranulated fertilizers. These products can enhance crop yields and improve soil health, aligning with the growing demand for sustainable agricultural practices. The company can expand its market presence by offering customized solutions tailored to specific crop and soil conditions. The global market for biological fertilizers is experiencing rapid growth, driven by the need to reduce reliance on synthetic fertilizers and promote environmental sustainability. Timeline: Ongoing.
  • Geographic Expansion: Bioceres can pursue growth through geographic expansion into new markets. While the company already operates in Argentina, Uruguay, France, and South Africa, there are opportunities to expand its presence in other regions with significant agricultural activity. This can be achieved through strategic partnerships, acquisitions, or direct investment. Expanding into new markets can diversify the company's revenue streams and reduce its reliance on specific regions. Timeline: Ongoing.
  • Strategic Partnerships and Acquisitions: Bioceres can accelerate its growth through strategic partnerships and acquisitions. Collaborating with other companies in the agricultural sector can provide access to new technologies, markets, and distribution channels. Acquiring complementary businesses can expand the company's product portfolio and strengthen its competitive position. Strategic partnerships and acquisitions can enhance Bioceres's ability to innovate and deliver comprehensive solutions to its customers. Timeline: Ongoing.

What Opportunities Does BIOX Have?

  • Expansion of HB4 technology adoption.
  • Growth in biological crop protection and nutrition segments.
  • Geographic expansion into new markets.
  • Strategic partnerships and acquisitions.

What Threats Does BIOX Face?

  • Competition from larger, more established players.
  • Regulatory changes and environmental concerns.
  • Fluctuations in commodity prices and weather patterns.
  • Economic and political instability in key markets.

What Are BIOX's Competitive Advantages?

  • Proprietary HB4 drought-tolerant technology.
  • Established presence in key agricultural markets.
  • Integrated approach to crop productivity solutions.
  • Focus on sustainable agricultural practices.

What Does BIOX Do?

Founded in 2001 and headquartered in Rosario, Argentina, Bioceres Crop Solutions Corp. has evolved into a provider of comprehensive crop productivity solutions. Originally conceived as a network of agricultural entrepreneurs, Bioceres transitioned into a publicly listed company focused on developing and commercializing agricultural technologies. The company operates through three primary segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment focuses on seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops and markets a range of products, including Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment offers inoculants, bio-inductors, and biological and microgranulated fertilizers. A key offering is HB4, a drought-tolerant seed technology program designed to enhance crop yields under water stress conditions. Bioceres operates in Argentina, Uruguay, France, South Africa, and other international markets, positioning itself as a global player in agricultural solutions.

What Products and Services Does BIOX Offer?

  • Develop and commercialize seed technology and biotechnological events.
  • Produce and market crop protection products, including herbicides and insecticides.
  • Offer crop nutrition solutions such as inoculants and bio-inductors.
  • Provide drought-tolerant seed technology through the HB4 program.
  • Operate in Argentina, Uruguay, France, South Africa, and internationally.
  • Focus on sustainable agricultural practices and solutions.
  • Develop germplasm and seed treatments.

How Does BIOX Make Money?

  • Develop and sell seed and integrated products.
  • Manufacture and distribute crop protection products.
  • Produce and market crop nutrition solutions.
  • Generate revenue through the sale of HB4 drought-tolerant seeds.

What Industry Does BIOX Operate In?

Bioceres Crop Solutions Corp. operates within the agricultural inputs industry, which is characterized by increasing demand for sustainable and efficient farming practices. The global market for agricultural inputs is driven by the need to enhance crop yields and improve food security. Key trends include the adoption of biotechnological solutions, precision agriculture, and biological crop protection products. Bioceres competes with established players in the seed, crop protection, and nutrition segments, differentiating itself through innovative technologies like HB4 and a focus on sustainable solutions. The industry is subject to regulatory oversight and is influenced by factors such as commodity prices, weather patterns, and government policies.

Who Are BIOX's Key Customers?

  • Farmers and agricultural producers.
  • Seed companies and distributors.
  • Agricultural cooperatives.
  • Governmental and non-governmental organizations.
AI Confidence: 72% Updated: May 10, 2026

Company Profile

Bioceres Crop Solutions Corp. operates in the Agricultural Inputs industry within the Basic Materials sector. It is headquartered in Rosario, AR. The company is led by CEO Federico Trucco. BIOX has traded publicly since 2018.

Bioceres Crop Solutions Corp. Financial Trajectory

Bioceres Crop Solutions Corp. (BIOX) reported $38.2M in revenue for Q1 2026, a decline of 48.2% compared to the prior quarter. The company recorded a net loss of $9.0M, with diluted EPS of $-0.14. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Basic Materials stock should monitor closely. Across the four most recent quarters, BIOX averaged $-0.96 in diluted EPS.

How Bioceres Crop Solutions Corp. Is Valued

Bioceres Crop Solutions Corp. carries a market capitalization of $22.96M, placing it in the micro-cap category. Relative to its peer group, BIOX's quantitative score of 42/100 is below the peer average of 64/100.

Key Financial Metrics

Return on assets is -46.7%, showing how much profit it generates from its asset base. A current ratio of 0.88 means current liabilities exceed short-term assets, a liquidity point worth watching.

F-Score 3/9Financial Health

Bioceres Crop Solutions Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.22 places it in the distress zone, a signal of elevated financial risk.

FY2026 estForward Outlook

Wall Street analysts project Bioceres Crop Solutions Corp. revenue of about $307.1M for fiscal 2026, with EPS near $-0.16.

BIOX Financials

Fundamental Snapshot

Revenue Growth (FY)
-28.3%
Free Cash Flow Growth (FY)
+86.4%
Return on Equity (TTM)
-151.3%
Current Ratio
0.9

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Innovative HB4 drought-tolerant technology.
  • Diversified product portfolio across seed, crop protection, and nutrition.
  • International presence in key agricultural markets.
  • Focus on sustainable agricultural practices.

Bear Case

  • Negative profit margin.
  • Relatively small market capitalization.
  • Dependence on specific technologies and markets.
  • Limited brand recognition compared to larger competitors.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2026 $38M -$9M -$0.14
Q4 2025 $74M -$183M -$2.88
Q3 2025 $77M -$7M -$0.12
Q2 2025 $74M -$44M -$0.70

Based on FMP financials and quantitative analysis

BIOX Latest News

BIOX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BIOX.

Price Targets

Consensus target: $2.00

BIOX MoonshotScore

42/100

What does this score mean?

The MoonshotScore rates BIOX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Federico Trucco

CEO

Federico Trucco has served as the CEO of Bioceres Crop Solutions Corp. since its inception. He has a strong background in agricultural biotechnology and business management. Prior to Bioceres, he held various leadership positions in the agricultural sector. Trucco holds a Ph.D. in Crop Sciences from the University of Illinois at Urbana-Champaign and an MBA from the Kellogg School of Management at Northwestern University.

Track Record: Under Federico Trucco's leadership, Bioceres has transformed from a network of agricultural entrepreneurs into a publicly listed company. He has overseen the development and commercialization of key technologies, including the HB4 drought-tolerant seed program. Trucco has also led the company's expansion into new markets and the diversification of its product portfolio. His strategic decisions have positioned Bioceres as a player in the agricultural solutions market.

BIOX Basic Materials Stock FAQ

What does Bioceres Crop Solutions Corp. do?

Bioceres Crop Solutions Corp. provides crop productivity solutions through its Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. It develops and commercializes seed technology, biotechnological events, and crop protection products. The company's HB4 drought-tolerant seed technology is a key offering, designed to enhance crop yields under water stress conditions. Bioceres operates in Argentina, Uruguay, France, South Africa, and internationally, focusing on sustainable agricultural practices and solutions.

What do analysts say about BIOX stock?

Analyst coverage of BIOX stock is limited, but generally focuses on the company's growth potential in the agricultural solutions market. Key valuation metrics include revenue growth, gross margin, and profitability. Analysts consider the company's HB4 technology a significant value driver, but also highlight the risks associated with competition and regulatory changes. The consensus is that BIOX has potential for long-term growth, but investors should carefully consider the company's financial performance and market conditions.

What are the main risks for BIOX?

The main risks for BIOX include competition from larger, more established players in the agricultural inputs industry, such as Bayer and Corteva. Regulatory changes and environmental concerns could impact the use of certain crop protection products, affecting the company's revenue. Fluctuations in commodity prices and weather patterns can also impact crop yields and demand, creating volatility in the market. Additionally, economic and political instability in key markets, particularly in Argentina, poses a risk to the company's operations and financial performance.

What are the key factors to evaluate for BIOX?

Bioceres Crop Solutions Corp. (BIOX) holds an AI score of 42/100 (low). Analysts target $2.00 (+451%). Not financial advice.

How frequently does BIOX data refresh on this page?

BIOX prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven BIOX's recent stock price performance?

Bioceres Crop Solutions Corp. (BIOX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative HB4 drought-tolerant technology. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BIOX overvalued or undervalued right now?

Valuing Bioceres Crop Solutions Corp. (BIOX) requires multiple metrics. Analysts target $2.00 (+451%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying BIOX?

Before investing in Bioceres Crop Solutions Corp. (BIOX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available company data and may be subject to change.
  • Financial metrics are based on the most recent available data.
  • Analyst opinions may vary.
Data Sources

Popular Stocks